Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells

Pancreatic cancer has the worst prognosis and lowest survival rate among all cancers. Pancreatic cancer cells are highly metabolically active and typically reprogrammed for aberrant glucose metabolism; thus they respond poorly to therapeutic modalities. It is highly imperative to understand mechanis...

Full description

Bibliographic Details
Main Authors: Sonam Kumari, Mohammed Sikander, Shabnam Malik, Manish K. Tripathi, Bilal B. Hafeez, Murali M. Yallapu, Subhash C. Chauhan, Sheema Khan, Meena Jaggi
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/12/1814
_version_ 1797506508505743360
author Sonam Kumari
Mohammed Sikander
Shabnam Malik
Manish K. Tripathi
Bilal B. Hafeez
Murali M. Yallapu
Subhash C. Chauhan
Sheema Khan
Meena Jaggi
author_facet Sonam Kumari
Mohammed Sikander
Shabnam Malik
Manish K. Tripathi
Bilal B. Hafeez
Murali M. Yallapu
Subhash C. Chauhan
Sheema Khan
Meena Jaggi
author_sort Sonam Kumari
collection DOAJ
description Pancreatic cancer has the worst prognosis and lowest survival rate among all cancers. Pancreatic cancer cells are highly metabolically active and typically reprogrammed for aberrant glucose metabolism; thus they respond poorly to therapeutic modalities. It is highly imperative to understand mechanisms that are responsible for high glucose metabolism and identify natural/synthetic agents that can repress glucose metabolic machinery in pancreatic cancer cells, to improve the therapeutic outcomes/management of pancreatic cancer patients. We have identified a glycoside, steviol that effectively represses glucose consumption in pancreatic cancer cells <i>via</i> the inhibition of the translation initiation machinery of the molecular components. Herein, we report that steviol effectively inhibits the glucose uptake and lactate production in pancreatic cancer cells (AsPC1 and HPAF-II). The growth, colonization, and invasion characteristics of pancreatic cancer cells were also determined by in vitro functional assay. Steviol treatment also inhibited the tumorigenic and metastatic potential of human pancreatic cancer cells by inducing apoptosis and cell cycle arrest in the G1/M phase. The metabolic shift by steviol was mediated through the repression of the phosphorylation of mTOR and translation initiation proteins (4E-BP1, eIF4e, eIF4B, and eIF4G). Overall, the results of this study suggest that steviol can effectively suppress the glucose metabolism and translation initiation in pancreatic cancer cells to mitigate their aggressiveness. This study might help in the design of newer combination therapeutic strategies for pancreatic cancer treatment.
first_indexed 2024-03-10T04:33:39Z
format Article
id doaj.art-5aa1d7ce0ba24d11938ce58be58d4d8f
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T04:33:39Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-5aa1d7ce0ba24d11938ce58be58d4d8f2023-11-23T03:55:59ZengMDPI AGBiomedicines2227-90592021-12-01912181410.3390/biomedicines9121814Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer CellsSonam Kumari0Mohammed Sikander1Shabnam Malik2Manish K. Tripathi3Bilal B. Hafeez4Murali M. Yallapu5Subhash C. Chauhan6Sheema Khan7Meena Jaggi8Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USADepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USAPancreatic cancer has the worst prognosis and lowest survival rate among all cancers. Pancreatic cancer cells are highly metabolically active and typically reprogrammed for aberrant glucose metabolism; thus they respond poorly to therapeutic modalities. It is highly imperative to understand mechanisms that are responsible for high glucose metabolism and identify natural/synthetic agents that can repress glucose metabolic machinery in pancreatic cancer cells, to improve the therapeutic outcomes/management of pancreatic cancer patients. We have identified a glycoside, steviol that effectively represses glucose consumption in pancreatic cancer cells <i>via</i> the inhibition of the translation initiation machinery of the molecular components. Herein, we report that steviol effectively inhibits the glucose uptake and lactate production in pancreatic cancer cells (AsPC1 and HPAF-II). The growth, colonization, and invasion characteristics of pancreatic cancer cells were also determined by in vitro functional assay. Steviol treatment also inhibited the tumorigenic and metastatic potential of human pancreatic cancer cells by inducing apoptosis and cell cycle arrest in the G1/M phase. The metabolic shift by steviol was mediated through the repression of the phosphorylation of mTOR and translation initiation proteins (4E-BP1, eIF4e, eIF4B, and eIF4G). Overall, the results of this study suggest that steviol can effectively suppress the glucose metabolism and translation initiation in pancreatic cancer cells to mitigate their aggressiveness. This study might help in the design of newer combination therapeutic strategies for pancreatic cancer treatment.https://www.mdpi.com/2227-9059/9/12/1814steviolpancreatic cancerglucose metabolismtranslation initiation
spellingShingle Sonam Kumari
Mohammed Sikander
Shabnam Malik
Manish K. Tripathi
Bilal B. Hafeez
Murali M. Yallapu
Subhash C. Chauhan
Sheema Khan
Meena Jaggi
Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
Biomedicines
steviol
pancreatic cancer
glucose metabolism
translation initiation
title Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
title_full Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
title_fullStr Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
title_full_unstemmed Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
title_short Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
title_sort steviol represses glucose metabolism and translation initiation in pancreatic cancer cells
topic steviol
pancreatic cancer
glucose metabolism
translation initiation
url https://www.mdpi.com/2227-9059/9/12/1814
work_keys_str_mv AT sonamkumari steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT mohammedsikander steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT shabnammalik steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT manishktripathi steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT bilalbhafeez steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT muralimyallapu steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT subhashcchauhan steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT sheemakhan steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells
AT meenajaggi steviolrepressesglucosemetabolismandtranslationinitiationinpancreaticcancercells